D-0998-2017 Class III Terminated
FDA drug recall D-0998-2017 was initiated by Valeant Pharmaceuticals North America LLC on Jun 28, 2017 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer… The recall status is terminated (terminated Jan 16, 2018). Affected quantity: 844 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 26, 2017
- Initiation Date
- Jun 28, 2017
- Termination Date
- Jan 16, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 844 bottles
Product description
Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02
Reason for recall
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.
Distribution pattern
U.S. Nationwide
Code information
Lot #: 2578400, 0Exp 8/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0998-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026